# Targeting Gut Microbiota and Metabolites for Very Preterm Infants Through Oropharyngeal Administration of Colostrum

> **NCT05481866** · NA · UNKNOWN · sponsor: **Shenzhen People's Hospital** · enrollment: 320 (estimated)

## Conditions studied

- Gut Microbiota
- Metabolites

## Interventions

- **OTHER:** Oropharyngeal administration of colostrum
- **OTHER:** Oropharyngeal administration of sterile water

## Key facts

- **NCT ID:** NCT05481866
- **Lead sponsor:** Shenzhen People's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-10
- **Primary completion:** 2023-10
- **Final completion:** 2023-10
- **Target enrollment:** 320 (ESTIMATED)
- **Last updated:** 2022-08-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05481866

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05481866, "Targeting Gut Microbiota and Metabolites for Very Preterm Infants Through Oropharyngeal Administration of Colostrum". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05481866. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*